tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:6628 Stock Latest News

Transcenta Licenses HiCB Biomanufacturing Platform to EirGenix in Strategic Collaboration
Company AnnouncementsTranscenta Licenses HiCB Biomanufacturing Platform to EirGenix in Strategic Collaboration
3h ago
6628
Transcenta’s Osemitamab Shows Promising Results in Cancer Trial
PremiumCompany Announcements
Transcenta’s Osemitamab Shows Promising Results in Cancer Trial
24d ago
6628
Transcenta Announces Share and Option Grants to Boost Strategic Goals
PremiumCompany Announcements
Transcenta Announces Share and Option Grants to Boost Strategic Goals
1M ago
6628
Transcenta Holding Limited Announces Auditor Change to Ernst & Young
PremiumCompany Announcements
Transcenta Holding Limited Announces Auditor Change to Ernst & Young
2M ago
6628
Transcenta’s Partner Inhibrx Reports Positive Phase 2 Results for Ozekibart in Chondrosarcoma
PremiumCompany Announcements
Transcenta’s Partner Inhibrx Reports Positive Phase 2 Results for Ozekibart in Chondrosarcoma
2M ago
6628
Transcenta Advances Financial and Strategic Initiatives to Strengthen Position
PremiumCompany AnnouncementsTranscenta Advances Financial and Strategic Initiatives to Strengthen Position
2M ago
6628
Transcenta Explores Blockchain-Based Financing for Oncology Innovations
Premium
Company Announcements
Transcenta Explores Blockchain-Based Financing for Oncology Innovations
3M ago
6628
Transcenta Completes HK$59.34 Million Share Placement
Premium
Company Announcements
Transcenta Completes HK$59.34 Million Share Placement
3M ago
6628
Transcenta Holding Limited Announces New Share Placement to Raise HK$59.34 Million
PremiumCompany Announcements
Transcenta Holding Limited Announces New Share Placement to Raise HK$59.34 Million
4M ago
6628
Transcenta Reports Interim Results with Strategic Adjustments
PremiumCompany Announcements
Transcenta Reports Interim Results with Strategic Adjustments
4M ago
6628
Transcenta Holding Limited Schedules Board Meeting to Review Interim Results
PremiumCompany Announcements
Transcenta Holding Limited Schedules Board Meeting to Review Interim Results
5M ago
6628
Transcenta Implements Strategic Measures to Enhance Financial Stability and Pipeline Development
PremiumCompany Announcements
Transcenta Implements Strategic Measures to Enhance Financial Stability and Pipeline Development
6M ago
6628
Transcenta Clarifies Option Grant to Consultant Dr. Caroline Germa
PremiumCompany AnnouncementsTranscenta Clarifies Option Grant to Consultant Dr. Caroline Germa
6M ago
6628
Transcenta Grants Shares and Options to Key Employees
Premium
Company Announcements
Transcenta Grants Shares and Options to Key Employees
6M ago
6628
Transcenta Holding Limited Announces Successful AGM Outcomes
Premium
Company Announcements
Transcenta Holding Limited Announces Successful AGM Outcomes
7M ago
6628
Transcenta Unveils Promising Osemitamab Trial Results at ASCO 2025
PremiumCompany Announcements
Transcenta Unveils Promising Osemitamab Trial Results at ASCO 2025
7M ago
6628
Transcenta Holding Limited Schedules 2025 Annual General Meeting
PremiumCompany Announcements
Transcenta Holding Limited Schedules 2025 Annual General Meeting
8M ago
6628
Transcenta Unveils Promising Preclinical Results for Novel Cancer Therapy
PremiumCompany Announcements
Transcenta Unveils Promising Preclinical Results for Novel Cancer Therapy
8M ago
6628
Transcenta Grants Award Shares to Employees Under Incentive Scheme
PremiumCompany Announcements
Transcenta Grants Award Shares to Employees Under Incentive Scheme
9M ago
6628
Transcenta Clarifies Annual Results Announcement
PremiumCompany AnnouncementsTranscenta Clarifies Annual Results Announcement
9M ago
6628
Transcenta Reports 2024 Financial Results with Strategic R&D Reprioritization
Premium
Company Announcements
Transcenta Reports 2024 Financial Results with Strategic R&D Reprioritization
9M ago
6628
Transcenta Holding Limited Schedules Board Meeting for Annual Results and Dividend Consideration
Premium
Company Announcements
Transcenta Holding Limited Schedules Board Meeting for Annual Results and Dividend Consideration
10M ago
6628

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >